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The human immunodeficiency virus type 1 (HIV-1) uses an elaborate alternative splicing pattern for the generation of both
the 1.8-kb as well as the 4-kb classes of mRNA. An additional diversity of transcripts in both classes is created by the optional
inclusion of the small exons 2 and 3 in the leader sequence. To analyze a possible influence of these leader exons on HIV-1
gene expression, several series of expression vectors with different leaders were constructed, expressing either Rev and Env
or a heterologous coding sequence, i.e., the chloramphenicol acetyl transferase (CAT) ORF. Transfection experiments of
HeLa-T41 cells revealed for all series of constructs that mRNA as well as protein expression was stimulated by the presence
of exon 2 and reduced by exon 3. The function of the leader exons 2 and 3 is neither dependent on the regulatory proteins
Tat or Rev nor on viral coding sequences. Neither transcription rates nor stability of polyadenylated RNAs were found to be
responsible for the different levels of steady-state mRNA. When either exon 2 or 3 was inserted into a heterologous intron,
processing of the primary transcripts generated identical mRNA species while maintaining the differences in exon 2/3-
dependent mRNA steady-state levels. These results may be explained by exon-specific nuclear RNA degradation rates, as
also indicated by results from an in vitro degradation assay using a HeLa nuclear extract. © 2001 Academic PressKey Words: HIV-1 gene expression; alternative leader exons; alternative splicing pattern; RNA stability; nuclear RNA
degradation; in vitro degradation assay.INTRODUCTION
Transcription of the proviral human immunodeficiency
virus type 1 (HIV-1) DNA is initiated at a single RNA
polymerase II promoter located in the 59 long terminal
epeat (LTR). The primary transcript corresponds to the
ull-length genomic RNA, which encodes 15 viral proteins
for review, see Frankel and Young, 1998). The virus uses
our strategies to solve the problem of expressing all 15
roteins from a single polycistronic primary transcript: (i)
he primary transcript is subjected to alternative splicing;
ii) several bi- and polycistronic mRNAs yield more than
ne translation product by leaky scanning (Furtado et al.,
991; Schwartz et al., 1992a) or reinitiation (Furtado et al.,
991); (iii) the pol gene is translated upon ribosomal
rameshifting (Jacks et al., 1988; Wilson et al., 1988); and
iv) proteolytic cleavage of polyprotein precursors, i.e.,
he Gag and Gag-Pol polyprotein precursors are proteo-
ytic cleaved sequentially by the viral proteinase to en-
ure the ordered maturation of the viral core (Wiegers et
l., 1998), while the Env glycoprotein is cleaved by a host
ellular proteinase (Decroly et al., 1997; Hallenberger et
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276al., 1992; Ohnishi et al., 1994). More than 20 exons,
resulting from the use of at least five splice donors and
11 splice acceptors, have been identified (Furtado et al.,
1991; Guatelli et al., 1990; Purcell and Martin, 1993; Rob-
ert-Guroff et al., 1990; Schwartz et al., 1990; Smith et al.,
1992) and combinations of these exons yield more than
40 mRNAs. In the course of viral gene expression, there
is a change in the formation of the predominant mRNAs
(Kim et al., 1989; Klotman et al., 1991). Thus, during the
early phase, only the 1.8-kb class of mRNAs encoding the
regulatory proteins is expressed, while the 4-kb class
and unspliced transcripts encoding the viral structural
proteins and enzymes appear late in the cytoplasm
(Cullen, 1991).
In both the 1.8- and 4-kb classes of spliced mRNAs,
transcripts have been identified that contain the small
leader exons 2 and 3 (Furtado et al., 1991; Muesing et al.,
1985; Purcell and Martin, 1993; Robert-Guroff et al., 1990;
Schwartz et al., 1990; Smith et al., 1992). In HIV-1-infected
lymphocytes, 52% of the 1.8-kb tat mRNAs, 20% of the rev
mRNAs, and 42% of the nef mRNAs contained exon 2,
exon 3, or both (Purcell and Martin, 1993). The splice
acceptors used for the formation of exons 2 and 3 are
significant, because they are required for the generation
of the vif and vpr mRNAs, respectively. Thus far, the only
evident purpose of splice donors 2 and 3 is to provide the
noncoding exons 2 and 3 in the 1.8- and 4-kb mRNAs.
The significance of exons 2 and 3 in the 1.8-kb mRNA
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277HIV-1 LEADER DEPENDENT GENE EXPRESSIONclass has been addressed in two studies resulting in the
conclusion that the presence of either exon 2 or 3 led to
no (Schwartz et al., 1990) increase or a moderate
(Muesing et al., 1987) increase of protein expression.
However, the conservation of these splice donors among
HIV-1 isolates and the stringent organization of the HIV-1
genome make it unlikely that their presence is fortuitous.
Previously we had identified an influence of the leader
sequences downstream of U5 (lsdU5) on HIV-1 gene
expression (Lenz et al., 1997). This observation prompted
us to reinvestigate a possible role of the alternative exon
2 and 3 leader sequences with appropriately constructed
expression vectors. Gene expression was found to be
stimulated by exon 2 and lowered by exon 3. The effects
of the exons were independent of the sequences down-
stream of the leader. The observed differences among
constructs on protein expression were paralleled by ef-
fects on the steady-state levels of mRNA. Minor differ-
ences in the transcription rates as well as in the degra-
dation rates of the polyadenylated mRNAs were too
small to explain the differences in protein and mRNA
levels. The effects of exon 2 and 3 on the RNA steady-
state levels were maintained when either exon 2 or 3
was placed between two functional heterologous splice
sites. Degradation of in vitro transcripts carrying the
noncoding exons, in a HeLa nuclear extract, revealed
differences in RNA stability that may account for the
respective different mRNA steady-state levels observed
in vivo. The findings indicate that the small leader exons
2 and 3 act as elements that regulate nuclear RNA
stability.
RESULTS
Construction of expression vectors for tat mRNAs
with different leader sequences
To investigate the role of the small leader exons 2 and
3 in HIV-1 gene expression, a set of expression vectors
was constructed containing the HIV-1 59 LTR, a cDNA of
an alternative tat mRNA leader and a subgenomic HIV-1
segment encoding Tat, Rev, Vpu, and Env (Fig. 1). To
exclude the possibility of transcription initiation at the 39
LTR, the sequence encoding the 39 untranslated region
was substituted with a region of SV40 carrying the small
t-intron and the polyadenylation signal. This precaution
was taken as we have observed transcription initiation at
the 39 LTR leading to read-around transcription with
several reporter constructs following cotransfection with
SVctat (Meinke, 1997; D. Meinke, H. Schaal, C. Lenz, and
A. Scheid, unpublished data). Thus, transcripts gener-
ated from the expression constructs represent authentic
viral mRNAs except for their 39 end. The vectors are
distinguished by the absence (construct LTR1.4E) or
presence of exon 2 (LTR1.2.4E), exon 3 (LTR1.3.4E), or
both leader exons (LTR1.2.3.4E). In addition, a leader
mutant with complete deletion of the exon 1 portion of
m
ithe leader sequence downstream of U5 (lsdU5) was
constructed (LTR1.4EDK/sj1.4) because this sequence
has been shown to be important for efficient HIV-1 gene
expression (Lenz et al., 1997). In plasmid LTR1.4EDn/B,
this sequence is partially deleted (cf. plasmid Dn/B in
Lenz et al., 1997).
Alternative leader sequences mediate different
expression of viral proteins
Tat expression from the leader series of constructs
was measured indirectly by quantification of the Tat-
induced CAT expression from a cotransfected reporter
plasmid (73LTRCATDEDS/P). Compared to the leader
construct LTR1.4E, the presence of exon 2 resulted in an
increase of protein expression, while exon 3 mediated a
lower expression (data not shown). Because interpreta-
tion of the observed effect of the leader on Tat expres-
sion is complicated by the fact that the translation prod-
uct, i.e., Tat, by itself influences the transcriptional activ-
ity, we set up a second series of experiments in which
Tat expression was inactivated by point mutation of the
tat translation initiation codon. This mutation allows effi-
cient translation of Rev, Vpu, and Env. The vectors of this
series (tat2 constructs) were analyzed by syncytium for-
mation. Forty-eight hours after transfection of HeLa-T41
cells, Env expression was scored by the number of cell
fusion events and the size of syncytia. With the complete
deletion of exon 1-lsdU5 in LTR1.4E tat2DK/sj1.4, only
very few and small syncytia were observed (Fig. 2A, cf.
columns 1.4 and 1.4DK/sj1.4), confirming an influence of
exon 1 sequences on Tat-independent HIV-1 gene ex-
pression (Lenz et al., 1997). Exons 2 and 3 also had a
striking impact on Env expression. Compared with con-
struct LTR1.4Etat2, the presence of exon 2 led to an
increase in both the number and the size of syncytia (Fig.
2A, cf. columns 1.4 and 1.2.4). The strong expression of
functional Env seen in transfections with the exon 2-con-
struct is remarkable since it is independent of Tat trans-
activation of the HIV-1 promoter. The insertion of exon 3
into LTR1.4Etat2 resulted in a lowered Env expression
Fig. 2A, cf. columns 1.4 and 1.3.4). In the presence of
oth leader exons 2 and 3, a slight increase was ob-
erved (Fig. 2A, cf. columns 1.4 and 1.2.3.4). Since Env
xpression is dependent on the presence of the viral
rans-activator Rev, these results also most likely reflect
ifferences in Rev expression. Therefore, we repeated
he experiments with coexpression of saturating
mounts of Rev in trans. As expected, the differences in
he number of syncytia in the presence of exon 2 or 3
ere now less pronounced, confirming an influence of
oth leader exons also on Rev expression (cf. Figs. 2A
nd 2B).
The differences in Env expression measured by Env-
ediated cell fusion were confirmed by Env detection
n immunoblots (Fig. 2C), which were strongest with
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278 KRUMMHEUER ET AL.construct LTR1.2.4Etat2, followed by the construct
acking exons 2 and 3 and the construct contain-
ng both exons. With the other constructs, Env expres-
FIG. 1. Schematic representation of (A) the HIV-1 provirus, (B) the g
elected exons, and expression vectors with different (D) wild-type and
of different RNA leaders, and the SV40 polyadenylation signal startin
constructs containing an HIV-1 segment encoding Tat, Rev, Vpu, and E
o AGG, and in the third series, e.g., LTR1.4tatCAT, HIV-1 ORFs are repl
xons 1, 2, and 3. For construction of the expression vectors, the restrion was undetectable in the immunoblot (Figs. 2C
nd 2D). cnfluence of the leader exons on the expression of a
eterologous gene
RNA with selected splice donors (SD) and splice acceptors (SA), (C)
ted leader sequences. All constructs contain the HIV-1 59 LTR, a cDNA
e XhoI site (X, nt 8887). LTR1.4E is a representative of one series of
another series of constructs, e.g., LTR1.4Etat2, the tat ATG is mutated
y the CAT ORF. Within each series, constructs differ in their content of
ites XhoI (X), NarI (N), KasI (K), and BssHII (B) were utilized.enomic
(E) muta
g at th
nv. InTo ask whether the HIV-1 coding sequences carry
is-elements that act in concert with the leader, a series
tt
2
g
t
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279HIV-1 LEADER DEPENDENT GENE EXPRESSIONof constructs was generated in which the HIV-1 se-
quences downstream of the tat ATG were substituted
with the CAT ORF.
HeLa-T41 cells were transfected with the CAT con-
structs alone or with increasing amounts (0.1, 0.5, and 1
mg) of the Tat-expression vector SVctat. The quantifica-
tion of CAT protein showed that the influence of the
leader exons on the expression of CAT was similar to the
effect in the HIV-1 context (Fig. 3A). When compared to
the construct LTR1.4tatCAT, the presence of exon 2 re-
sulted in 2.6-fold increase in CAT expression, whereas
exon 3 caused a 6.6-fold decline. When both leader
exons were simultaneously present, a slight decrease in
CAT expression was observed.
It should be emphasized that CAT expression from
construct LTR1.2.4tatCAT approached the expression ef-
ficiency of the reference vector pSVT7CATDE, in which
the CAT gene is under the control of the SV40 early
promoter. This result strengthens the previous conten-
tion (Lenz et al., 1997) that even in the absence of Tat the
HIV-1 promoter displays an activity that is adequate for
efficient protein expression, provided that the native
leader sequence is maintained.
FIG. 2. Glycoprotein expression in HeLa-T41 cells 48 h after transfec
heir number and size (number of nuclei per syncytium) and the results w
0 mg of each tat2 leader construct. (B) Number and size of syncytia i
lycoprotein as shown in (A) after the transfer onto a PVDF membrane.
o gp120. (D) For normalization, the lower part of the blot was reacted w
CL-system (Amersham) as described under Materials and Methods. L
(1.2.4); 4, LTR1.3.4tat2 (1.3.4); 5, LTR1.2.3.4tat2 (1.2.3.4).Cotransfections of SVctat with each CAT construct led
o an increase of CAT expression (Fig. 3B). Irrespective ofthe amount of cotransfected SVctat, the qualitative differ-
ences in the leader dependence were maintained. With
the highest amount of cotransfected SVctat, i.e., 1 mg, Tat
trans-activation approached distinct saturation levels
with each construct. This indicates that the mechanism
of the leader effects is independent of Tat-mediated
transcriptional activation.
Influences of the leader elements on the mRNA
steady-state level
To analyze the mechanism responsible for the ob-
served leader-mediated differences in protein expres-
sion, mRNA steady-state levels were measured by
Northern blot analysis. The CAT constructs were trans-
fected into HeLa-T41 cells and poly(A)1 RNA from total
RNA was probed with a CAT-specific antisense RNA
(Fig. 4A). mRNA levels were quantified by chemilumi-
nescence measurement in conjunction with laser den-
sitometry of exposed films (Fig. 4C). A correlation was
observed between CAT mRNA and protein expression
(compare Fig. 4C with Fig. 3A). Thus, the 2.6-fold
th the series of tat2 constructs. (A) Syncytia were scored according to
rmalized for transfection efficiency. Transfections were performed with
resence of saturating amounts of Rev. (C) Immunoblot analysis of the
t was cut and the upper part was reacted with a monoclonal antibody
olyclonal antibody to luciferase (luc). Bands were visualized using the
, LTR1.4E tat2DK/sj1.4 (1.4DK/sj1.4); 2, LTR1.4Etat2 (1.4); 3, LTR1.2.4Etat2tion wi
ere no
n the p
The blo
ith a pincrease in CAT protein amount mediated by the ad-
ditional exon 2 compared with a 2.4-fold increase in
c
R
C
e
C (B) CAT
e cells w
280 KRUMMHEUER ET AL.mRNA level, and, between the exon 2- and exon 3-con-
taining vectors, the 17-fold difference in protein ex-
pression correlated with a factor of 23 at the mRNA
level. The presence of both leader exons, 2 and 3,
resulted in a twofold decrease in the mRNA levels,
showing that the negative effect of leader exon 3 could
not be fully compensated by exon 2.
No effect of the leader exons on nuclear-cytoplasmic
RNA distribution
To address the question of whether the leader ex-
ons affect the nucleocytoplasmic RNA transport of the
glycoprotein mRNA, cells transfected with the tat2
series of constructs were fractionated into a nuclear
and cytoplasmic fraction prior to RNA isolation. The
Northern blot analysis of cytoplasmic mRNAs showed
a comparable leader-dependent abundance of mRNAs
as with the CAT constructs (cf. Figs. 5 and 4). The
correspondence between the levels of spliced and
unspliced mRNAs excludes the possibility that low
levels of unspliced mRNAs were due to efficient splic-
ing. With different leader constructs, the abundance of
nuclear RNA paralleled that found in the cytoplasm
(Fig. 5, cf. cytoplasmic vs nuclear), suggesting that the
FIG. 3. CAT protein expression in HeLa-T41 cells transfected with the
AT construct and CAT protein was quantified 48 h after transfection
xpressed as the mean of at least three independent transfections 6 s
AT expression of pSVT7CATDE-transfected cells was set at 100%.
xpression vector SVctat. CAT expression of pSVT7CATDE-transfectedleader exons exert their influence on gene expression
most likely within the nuclear compartment.The transcription rate does not account for the
effects of the small leader exons
The correlation between protein and mRNA expres-
sion argues against an influence of the small leader
exons at the translational level. Thus, the different effects
mediated by exons 2 and 3 could either be due to an
influence on the promoter activity or to posttranscrip-
tional events within the nuclear compartment. To analyze
the first possibility, nuclear run-on transcription assays
were carried out with nuclei of transfected cells (Fig. 6).
The observed differences in the relative transcription
rates (factor , 2) were too small to explain the big
differences in mRNA steady-state levels as measured by
Northern blotting. This shows that the leader exons 2
and 3 have no or only minor effects on basal HIV-1
promoter activity and indicates that the leader-depen-
dent variation in steady-state mRNA levels must involve
posttranscriptional processes.
The leader exons do not alter poly(A)1 RNA stability
To address the question of whether the leader exons
onfer different rates of RNA breakdown, we performed
NA stability measurements in transfected HeLa-T41
cells. Cells were treated with actinomycin D 24 h after
transfection to inhibit transcription. Poly(A)1 RNA from
of CAT constructs. HeLa-T41 cells were transfected with 10 mg of each
n ELISA. Results are normalized to equal transfection efficiency and
error of the mean. (A) Basal, Tat-independent CAT protein expression.
expression after cotransfection with increasing amounts of the Tat
as set at 1.series
with a
tandardtotal RNA was analyzed by Northern blot during a 6-h
time course (Fig. 7). The poly(A)1 RNAs decayed inde-
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281HIV-1 LEADER DEPENDENT GENE EXPRESSIONpendently of their leader to approximately 50% of their
initial level within the first hour of antibiotic treatment
(Fig. 7). This rapid decay seemed to be accompanied by
a decrease in the size of the poly(A)1 RNA, which may be
due to poly(A) tail length shortening preceding turnover
of the RNA body. Between 1 and 6 h after addition of
actinomycin D, a much slower rate of decay was ob-
served for all transcripts. Thus, the leader exon-mediated
mRNA steady-state levels can neither be explained by
the rate of synthesis nor the half-lives of the polyadenyl-
ated transcripts.
The influences of the leader elements are maintained
when they are expressed as introns
In an attempt to attribute the influence of the leader
FIG. 4. Northern blot analysis of mRNA from total RNA isolated from
HeLa-T41 cells transfected with the series of CAT constructs. Poly(A)1
RNA isolated from HeLa-T41 cells transfected with 10 mg of the CAT
constructs was subjected to formaldehyde-agarose gel electrophoresis
and blotted onto a nylon membrane as described under Materials and
Methods. (A) Blot probed with a digoxigenin (DIG)-labeled CAT-specific
antisense RNA. (B) Reprobing of the same blot for hGH mRNA derived
from the cotransfected (5 mg) plasmid pXGH5. The DIG-labeled probes
ere visualized with an anti-DIG alkaline phosphatase conjugate and
hemiluminescence. Lanes: 1, LTR1.4tatCAT; 2, LTR1.2.4tatCAT; 3,
TR1.3.4tatCAT; 4, LTR1.2.3.4tatCAT. (C) Northern blot analyses were
uantified using chemiluminescence in conjunction with laser densi-
ometry. hGH mRNA was used as the standard to normalize the CAT
ybridization signals. CAT mRNA expression of LTR1.4tatCAT was set at
00%.exons to the processing of the transcripts, the leader
exons 2 and 3 were placed between splice sites up- fstream of the CAT reporter gene (cf. Figs. 8A and 1, and
Materials and Methods). Pre-mRNAs transcribed from
these constructs diverge due to different intron se-
FIG. 5. Northern blot analysis of RNA isolated from HeLa-T41 cells
transfected with tat2 leader constructs. (A) HeLa-T41cells were co-
transfected with 20 mg of each leader construct and 20 mg of pXGH5.
Cytoplasmic and nuclear fractions were obtained 30 h after transfection
as described under Materials and Methods. Poly(A)1 RNA isolated from
30 mg of cytoplasmic RNA (left) and 4 mg of nuclear RNA (right) were
ubjected to formaldehyde-agarose gel electrophoresis and blotted
nto a nylon membrane. The blot was probed simultaneously with
IG-labeled antisense RNAs corresponding to env sequences from nt
648–8887 and to exon 5 sequences in hGH mRNA. Arrows indicate
he unspliced (us) and spliced (s) mRNAs. The DIG-labeled probes
ere visualized with an anti-DIG alkaline phosphatase conjugate and
hemiluminescence. Lanes: 1, LTR1.4Etat2; 2, LTR1.2.4Etat2; 3,
LTR1.3.4Etat2; 4, LTR1.2.3.4Etat2. (B) Longer exposure of the signal of
the unspliced RNA.
FIG. 6. Transcription rates in nuclei isolated from cells transfected
with the CAT constructs as determined by nuclear run-on transcription.
The incorporation of [a-32P]UTP into elongating CAT transcripts was
etermined by hybridization to 5 mg CAT antisense RNA (as CAT)
immobilized onto nylon membranes. Hybridization of hGH mRNA de-
rived from the cotransfected plasmid pXGH5 to 5 mg hGH antisense
RNA (as hGH) was used to normalize the CAT signals. CAT (s CAT) and
hGH (s hGH) sense RNA served as controls. The relative transcription
32rates (RTR) were obtained by P-phosphorimaging and are corrected
or the uridine content of the CAT transcripts.
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282 KRUMMHEUER ET AL.quences, whereas the processed transcripts are identi-
cal. Transfection of HeLa-T41 cells with the vector con-
taining exon 2 as intron showed a 1.7-fold increase in
CAT expression. Conversely, transfecting the vector with
exon 3 flanked by splice sites resulted in a 3.3-fold
decrease in reporter protein (Fig. 8B). The conservation
of the exon-dependent expression pattern suggests that
the leader exons exert their influence prior to the splicing
process.
To ensure that the inserted splice sites flanking exons
2 and 3 mediated removal of the enclosed exon se-
quences, the transfection experiment was repeated and
cytoplasmic poly(A)1 RNA was analyzed by Northern blot
analysis (Fig. 8C). The size of the detected CAT tran-
scripts was found to be identical, indicating efficient
removal of the introns independent of their sequence. No
hybridization signal was obtained corresponding to the
unspliced transcripts, which would have been easily
detected under these experimental conditions (data not
shown). Quantification of the hybridization signals re-
FIG. 7. Analysis of poly(A)1 RNA stability determined by actinomycin
was inhibited by addition of actinomycin D, poly(A)1 RNA was isolate
nalysis. The RNA was probed and detected as described in legend to
hown for each construct. RNA levels were assayed by laser densitom
00%.vealed a 1.3-fold exon 2-dependent increase and an
4.4-fold exon 3-dependent decrease in the steady-state
c
tcytoplasmic poly(A)1 RNA levels. The correlation be-
ween CAT protein and cytoplasmic poly(A)1 RNA ex-
ression suggests that the alternative leader exons 2
nd 3 modulate HIV-1 gene expression shortly after RNA
ynthesis.
lternative leader sequences mediate different RNA
tability in vitro
To analyze whether distinct nuclear degradation rates
re the cause for the observed differences in the leader-
ependent gene expression, the RNA stability of in vitro
ranscripts in a HeLa nuclear extract was analyzed. For
his purpose the U3 sequences of the LTR1.4E vector
eries (cf. Fig. 1) was substituted for the T7 promoter and
inearized the plasmids were with SalI (cf. Materials and
ethods). Thus, the transcription initiation site to gener-
te the in vitro transcripts is identical to the initiation site
f authentic HIV-1 transcripts. Since the cap structure is
nown to influence strongly the mRNA stability, espe-
e. Twenty-four hours after transfection transcription in HeLa-T41 cells
total RNA during a 6-h time course and subjected to Northern blot
o ensure comparable signal intensities, individual exposure times are
nalysis and shown graphically with the amount of RNA at t 5 0 set atD chas
d from
Fig. 4. Tially in the nucleus, we compared the nuclear degrada-
ion rates of capped and uncapped transcripts. Incuba-
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283HIV-1 LEADER DEPENDENT GENE EXPRESSIONtion of 32P-labeled uncapped transcripts with HeLa nu-
lear extract (Fig. 9A) but not water (Fig. 9C) revealed that
FIG. 8. Analysis of gene expression from the series of CAT constructs
with exon sequences placed within an intron. (A) Schematic drawing of the
constructs of the LTR (SDSA) tatCAT-MCS-pA series. R and U5 as part of
the leader sequence are depicted as a shaded box, followed by the leader
sequences downstream of U5 (lsdU5), which extends to the primary splice
donor (SD). The minimal intron consists of restriction sites (vertical bars)
and a functional branch site (BS) in appropriate distance to the splice
acceptor (SA). The two shaded boxes above indicate the inserted se-
quences of the noncoding exons 2 and 3. The shaded arrow represents
the CAT ORF replacing the tat ORF. (B) CAT protein expression in HeLa-T41
cells transfected with the series of CAT constructs. HeLa-T41 cells were
ransfected with 1 mg of each CAT construct and cotransfected with 0.1 mg
SVctat and 0.5 mg pGL3 control (Promega) using FuGENE 6 Transfection
reagent according to the manufacturer’s protocol (Roche Molecular Diag-
nostics). CAT protein was quantified 48 h after transfection with an ELISA.
Results are normalized to equal transfection efficiency and expressed as
the mean of at least three independent transfections 6 standard error of
the mean. Column 1: CAT expression of LTR (SDSA) tatCAT-MCS-pA was
set as 1; column 2: LTR (SDEX2SA) tatCAT-MCS-pA; column 3: LTR
(SDEX3SA) tatCAT-MCS-pA. (C) The poly(A)1 RNA fraction of 40 mg of the
cytoplasmic RNA of HeLa-T41 cells, cotransfected with 10 mg of each CAT
onstruct, 1 mg SVctat and 5 mg pXGH5, was subjected to Northern blot
nalysis. CAT mRNA expression of LTR (SDSA) tatCAT-MCS-pA was set as
. Lane 1: LTR (SDSA) tatCAT-MCS-pA; lane 2: LTR (SDEX2SA) tatCAT-
CS-pA; Lane 3: LTR (SDEX3SA) tatCAT-MCS-pA.he alternative leader sequences affect RNA stability in
itro. After 120 min incubation, the presence of exons 2nd 3 resulted in a 2.1-fold higher and 2.4-fold lower
mount of remaining RNA, respectively, compared to
ranscript 1.4. As observed before for the RNA steady-
tate levels following the transfection experiment (cf. Fig.
), the presence of both exons led to a reduction which
as not as pronounced as with exon 3 alone. In the
resence of the cap structure exon 2 still leads to a delay
n RNA degradation, whereas the destabilization effect
ediated by exon 3 seems to be moderated (Fig. 9B).
The markedly reduced kinetics in the presence of the
ap structure raises the possibility that in vivo cotrans-
riptional capping of the transcripts which contain a 59
tem-loop structure, i.e., the TAR structure, may be im-
eded while the observed exon-mediated nuclear RNA
egradation takes place.
DISCUSSION
In the present study we demonstrate with four different
ets of eucaryotic expression vectors that gene expres-
ion is differentially regulated by the HIV-1 leader exons
and 3, i.e., stimulated by exon 2 and lowered by exon
. Since the effects of exons 2 and 3 were observed in
he natural HIV-1 context as well as in the artificial CAT
xpression system, the influence of the leader exons
ppears to be neither dependent on the viral regulatory
roteins Tat and Rev nor on the presence of HIV-1 coding
equences.
The role of the small leader exons 2 and 3 has been
nvestigated earlier with Tat expression vectors
Muesing et al., 1987). In that system, the presence of
xons 2 and 3 in alternate tat cDNAs resulted in a two-
nd fivefold stimulation of CAT expression from an LTR-
AT reporter plasmid (Muesing et al., 1987). In contrast
o these findings, evidence obtained in our laboratory
ith similar constructs containing the SV40 early pro-
oter and an HIV-1 39 LTR to provide the poly(A) signal
ndicate that in the presence of Tat, genes upstream of
he 39 LTR are downregulated, while 39 genes are up-
egulated (Meinke, 1997; D. Meinke, H. Schaal, C. Lenz,
nd A. Scheid, unpublished data). A different study ana-
yzed the effects of the leader exons 2 and 3 in conjunc-
ion with leader exons 1 and 5 in nef cDNAs (Schwartz et
l., 1990). While the authors conclude from their immu-
oprecipitation data that Nef was expressed in the pres-
nce of exons 2 or 3 as well as in their absence, their
ata also show a stimulatory effect of exon 2 in accor-
ance with our findings, although in this study the pos-
ibility remains that the observed differential effects of
xons 2 and 3 may depend on the presence of exon 5.
Our analysis of RNA steady-state levels shows a cor-
espondence with protein expression among the tat2
constructs as well as among both series of CAT vectors.
The differential effects of exons 2 and 3 appear to be
maintained independent of their exonic or intronic posi-
tion pointing against a significant effect of the leader
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284 KRUMMHEUER ET AL.sequences on the translational efficiency. The observed
transcription rates differ by a factor of less than 2, which
is far too small to account for the significant differences
in RNA steady-state levels. In addition actinomycin D
chase experiments show no significant differences in the
half-lives of polyadenylated transcripts. Thus, it appears
that neither translation nor transcription initiation nor
breakdown of the polyadenylated transcripts are notably
regulated by leader exon sequences. Since the leader
exon sequences exert their effect even when removed by
FIG. 9. Nuclear degradation assay of in vitro transcripts containing
ith nuclear extract as described under Materials and Methods. Aliquo
enaturing gel electrophoresis. Quantification was performed by 32P-pho
with the amounts of the input transcript at 0 min. Results with transc
degradation assays 6 standard error of the mean. (B) Nuclear degrada
transcripts using ddH2O instead of nuclear extract with aliquots takensplicing, they seem to affect an early step of the RNA life
cycle. The exon-mediated differential steady-state
s
ppoly(A)1 RNA levels could be explained by different nu-
lear RNA degradation which has been previously de-
cribed as the cause for a reduced cytoplasmic steady-
tate level of HIV-1 transcripts using the proximal poly(A)
ite (Scott and Imperiale, 1997). This concept is further
upported by results obtained in our in vitro nuclear
egradation assay which shows differences in RNA lev-
ls comparable to those seen in vivo when uncapped
ranscripts were analyzed. However, capping of the in
itro transcripts masked these differences. It may be
erent leader exons. (A) [a-32P]UTP-labeled transcripts were incubated
e taken after 0, 5, 10, 30, 60, and 120 min incubation and subjected to
maging. The amounts of RNA remaining after 120 min were normalized
T71.4 were set as 1. Data represent the mean of three independent
apped transcripts. (C) Corresponding control experiment of uncapped
, 30, 60, and 120 min incubation.the diff
ts wer
sphori
ript ofpeculated that the exon-mediated degradation occurs
rior to the capping reaction, which has been shown to
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285HIV-1 LEADER DEPENDENT GENE EXPRESSIONtake place as transcription passes the Pol II, pausing at
promoter-proximal positions (O’Brien et al., 1994; Ras-
mussen and Lis, 1993). However, this cotranscriptional
capping might be delayed for the TAR-containing HIV-1
transcripts. Following this hypothesis, the rapid degra-
dation of short transcripts tailored by the use of a pro-
moter-proximal poly(A) site (Scott and Imperiale, 1997)
could also be explained by a delayed capping reaction.
Sequence elements that negatively modulate the RNA
stability are known as cis-acting inhibitory sequences
INS, IR, or CRS) and were identified within the HIV-1 gag,
ol, and env gene. Their role in mediating the Rev re-
sponse has been investigated in several studies (Brighty
and Rosenberg, 1994; Cochrane et al., 1991; Hadzopou-
lou Cladaras et al., 1989; Maldarelli et al., 1991; Mikaelian
et al., 1996; Nasioulas et al., 1994; Reddy et al., 1995;
osen et al., 1988; Schneider et al., 1997; Schwartz et al.,
992b,c). For several INS elements in HIV-1 mRNAs it has
een shown that the RNA instability correlates with the
U content (Schneider et al., 1997; Schwartz et al.,
992b,c). Preliminary results revealed that a reduction of
he AU content reduces the destabilizing effect of exon 3
data not shown), similar to a reduction resulting in in-
ctivation of INS1 (Schwartz et al., 1992b), INS2, and
NS3 (Schneider et al., 1997).
The occurrence of alternative 59 untranslated regions
s a common feature in cellular transcripts. However, the
eterogeneity in the leader regions of cellular and HIV-1
ranscripts is generated by different molecular mecha-
isms. In cellular mRNAs it is mainly due to different
ranscription initiation sites, each controlled by a distinct
romoter. The control of a single gene by alternative
romoters has been shown in several instances to en-
ble a tissue- or development-specific expression of
enes (Danielson et al., 1993; Lowe et al., 1987; Nielsen
t al., 1990; Reynolds et al., 1985; Saitta et al., 1992).
Transcription of the proviral HIV-1 DNA differs from
transcription of these cellular genes in that only one
transcriptional start site is present in the viral genome.
Thus, the heterogeneity in the 59 untranslated region of
the viral mRNAs is solely generated by alternative splic-
ing. It seems possible that HIV-1 uses alternative splicing
to express its genes in a cell-dependent manner analo-
gous to the tissue- or development-specific gene expres-
sion mediated by alternative promoters. This hypothesis
is supported by the differences in the viral splicing pat-
tern that are apparent from studies investigating HIV-1
RNA expression (Furtado et al., 1991; Guatelli et al., 1990;
Purcell and Martin, 1993; Robert-Guroff et al., 1990;
Schwartz et al., 1990; Smith et al., 1992). For example,
inclusion of exon 5 in the 1.8-kb RNA class has been
found to vary between 20% in HIV-1 BAL-infected mac-
rophages and 60% in HTLV IIIB-infected H9 cells (Robert
Guroff et al., 1990). The cell type-specific distribution of
different leaders may be the result of distinct stability
modulating effects. Inclusion or excision of distinct se-quences would alter the nuclear dwell time during which
RNA stability is affected. The optional leader exons might
enable a cell type-specific fine tuning of viral gene ex-
pression, depending on the presence of proteins that
modulate RNA stability in combination with differences in
splicing kinetics.
MATERIALS AND METHODS
Oligonucleotides
Oligonucleotides were synthesized and purified as
previously described (Schaal et al., 1995). Restric-
tion sites used for cloning are italicized. 135:
59-GGGTGTCGACATAGCAGAATAGGCGTTACTCGACAGA-
GGAGAGCAAGAA, 136: 59-GTCTAGGATCTACTGGAGGC-
CTTTCTTGCTCTCCTCT, 214: 59-ATCGAATTCAGTAGTGTGT-
GCCCGTCTGTTG, 311: 59-ATCGAATTCGGGTCTCTCTG, 318:
59-ACCCAATTGAAGTGCTAAGG, 329: 59-AAGTCTCTCA-
AGCGGTGGTAG, 377: 59-CTGAAGCGCGCACGGCAAGAG-
GCGAGGGGAGGCGACTG, 538: 59-GAAAGGACCAG-
CAAAGCTCCTCTGGAAAGACTCTGCTATAAGA, 539:
59-GAAGCGCGCACGGCAAGAGGCGAGGGGAGGCGAC-
TGACTCTGCTATAAGA, 540: 59-CTATGTCGACACCCAAT-
TCTTGTTATGTCCTG, 613: 59-GCGCCAATTGGGTG, 614:
59-TCGACACCCAATTG, 662: 59-GATATCACCGGTGGATC,
663: 59-CATGGATCCACCGGTGATATCACGT , 683:
59-TCACCCGGGCCCTAATACGACTCACTATAGGGTCTCTC
TGGTTAGACCAGATCTGAGCCTGGGAGCTCTCATCTAG-
AACACCATGGGCAAATATTATACGC, 684: 59-AACAGAT-
CTGAAGAC(T) 3 2 CTCGAGGGCACCAATAACTGCC-
TA, 743: 59-CCAGCTGCAGCGCTTTCCAGAGGAGC,
45: 59-CCAGCTGCAGCGCTTGTTATGTCCTGC, 788:
9-GGCCTCGAGCTGTTTTTAAGCCTAATGTG, 789:
9-GATGAATTCATATATCTTAATGGCACATGC, 822:
59-TCTAGAATTCTCTCTTCTGCCGTT, 823: 59- AGCGCTC-
GAGGGACAGCCAGGCCA, 918: 59-GCTATGTCGAC-
AAGGAGCTGCAGATCGATGAATTCGATACTTACCAGTCGC
CTCCCCTC, 922: 59-GAGCGAATTCACTCTGCTATAAGAAAG-
GCCT, 923: 59-GAGCGAATTCGGACAGCAGAGATCC, 931:
59-GCTATGTCGACACCCAATTCTGAAACGATAATGGTGAAT-
ATCCCTGCCTAACTCTATTCACTATA, 932: 59-ATCCTGCA-
GAATAGTTTTTGCTGTACTTTCTATAGTGA.
Recombinant plasmids
HIV sequences were derived from the plasmid pNLA1
(Strebel et al., 1987), a cDNA derivative of pNL4-3 (Adachi
et al., 1986) which lacks the gag gene and most of the pol
gene. The nucleotide numbering system used is that of
the parent sequence HIVNL43 (Myers et al., 1995).
The construction of plasmid LTR1.4E has been de-
scribed (Lenz et al., 1997). The 59 73 nt of lsdU5 (nt 1183
to 1255) in this vector were deleted by ligation of the AflII
(nt 517)–KpnI (nt 6343) vector fragment of LTR-E/X-pA
(Schaal et al., 1993), the AflII–SalI (nt 5785) insert of
LTRtatCATDn/B (Lenz et al., 1997), and the SalI–KpnI
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286 KRUMMHEUER ET AL.insert of SpNLA1 (see below), yielding plasmid
LTR1.4EDn/B.
Plasmid LTR1.4EDK/sj1.4: To delete the exon 1-derived
lsdU5 element, the 115-bp KasI (nt 637)–SalI fragment of
LTR1.4E was replaced by a KasI–SalI linker consisting of
annealed (20 min at 37°C) oligonucleotides 613 and 614.
The plasmids LTR1.2.4E, LTR1.3.4E, and LTR1.2.3.4E
were constructed by ligation of the SacI (nt 487)–KpnI
vector fragment of LTR-E/X-pA, the SalI–KpnI insert of
SpNLA1, and the SacI–SalI inserts of LTR1.2.4tatCAT,
TR1.3.4tatCAT, and LTR1.2.3.4tatCAT (see below), re-
pectively.
Plasmids LTR1.4Etat2 and LTR1.4Etat2Dn/B have been
escribed (Lenz et al., 1997). For the introduction of point
utations into the tat translational start codon in plas-
mids LTR1.4EDK/sj1.4, LTR1.2.4E, LTR1.3.4E, and
LTR1.2.3.4E, the 562-bp SalI–KpnI fragments of these
plasmids were replaced with the corresponding insert of
SpNLA1tat2 (see below) in which a StuI site had been
nserted into the first and second codons of the tat ORF.
Plasmid LTR1.4tatCAT has been described previously
Lenz et al., 1997). To insert the small leader exon 2 into
TR1.4tatCAT, the 114-bp NarI (nt 637)–SalI fragment of
he parent vector was replaced with the 164-bp NarI–SalI
ragment of plasmid pUHctatcrev1.2.4, yielding plasmid
TR1.2.4tatCAT. For the construction of pUHctatcrev1.2.4,
mg of total RNA, isolated 48 h after transfection with
UHctatcrev (Schaal et al., 1993), was reverse tran-
cribed using rTth DNA polymerase (Perkin–Elmer) with
rimer 329, and the cDNA was amplified with primers
11 and 318. The PCR product was digested with EcoRI
nt 5743) and BamHI (nt 8465) and cloned into pUH3
Schaal et al., 1993). The resulting clone A10/21, carrying
exon junctions 1.2.4.7, was digested with BssHII (nt 711)
and BamHI, and the insert was used to replace the
BssHII—BamHI fragment of pUHctatcrev.
For the insertion of leader exon 3, the 40-bp BssHII–
SalI fragment of LTR1.4tatCAT was substituted with a
synthetic insert generated by PCR with the primer pair
539/540 and pNLA1 as a template, yielding plasmid
LTR1.3.4tatCAT.
For construction of LTR1.2.3.4tatCAT, two separate
PCRs using pNLA1 as a template were run: PCR 1 using
the primer pair 538/540, PCR 2 with the 59 primer 214 and
the product of PCR 1 as the 39 primer. The final product
was cut with NarI and SalI and used to replace the
114-bp NarI–SalI fragment of LTR1.4tatCAT.
Plasmid 73LTRCATDEDS/P contains the HIV-1 59 LTR
of plasmid pNLA1, the CAT gene of plasmid EcoCATDE
(Lenz et al., 1997), and the SV40 polyadenylation signal of
plasmid pSVT7 (Bird et al., 1987).
The construction of SpNLA1 was carried out by en-
larging the multiple-cloning site of pSVT7 so that a
unique synthetic XhoI site was inserted 59 to the XbaI
site, resulting in pSVT7-X. The pSVT7-X sequence be-
tween the EcoRI site and the new XhoI site was ex-
p
echanged with the EcoRI–XhoI fragment of pNLA1 (nt
5743–8887), resulting in SpNLA1.
Exchange of the EcoRI–KpnI fragment (nt 5743–6343)
in SpNLA1 with the corresponding fragment of pUH3tat2
resulted in SpNLA1tat2. The construction of pUH3tat2
involved a modification in the multiple cloning site of
pGEM-3Zf(2) (Promega, Madison, WI): (1) Excision of the
SalI–HindIII fragment and nonhomologous end joining
with Xenopus egg extract (Schaal et al., 1993), resulting
in the elimination of these restriction sites (pUH1); (2)
insertion of the EcoRI–KpnI fragment of pNLA1 (nt 5743–
6343) yielding pUH3; (3) exchange of the SalI–KpnI frag-
ment (nt 5785–6343) with the synthetic SalI–XhoII frag-
ment (oligonucleotides 135/136) in tandem with the
XhoII–KpnI fragment (nt 5841–6343) of pUH3 (pUH3tat2).
For the synthesis of the SalI–XhoII fragment, pairs of
single-stranded oligonucleotides were converted to dou-
ble-stranded DNA by a cyclic “fill-in” method based on
PCR.
Plasmids SVctat and SVcrev were generated from
SpNLA1 by replacing the EcoRI–XhoI (nt 8887) fragment
with the corresponding insert of pUHctat and pUHcrev,
respectively (Schaal et al., 1993).
LTR1.4tatCAT-MCS-pA differs from LTR1.4tatCAT by the
presence of an additional multiple cloning site 39 of the
CAT ORF. LTR (SDSA) tatCAT-MCS-pA was generated by
the sequential insertion of the PCR cyclic fill-in products
918/377 and 931/932 into the BssHII/SalI and PstI/SalI
sites of the vector, respectively. Exon 2 and 3 have been
amplified using PCR primers 923/743 and 922/745 and
pNLA1 as template, allowing their insertion into the in-
tron of LTR (SDSA) tatCAT-MCS-pA using the EcoRI and
PstI sites.
For the construction of plasmid pb-actin intron, nucle-
otides 1729–2050 of intron c of human b-actin (GenBank
ccession No. E00829) have been PCR-amplified with
rimers 822 and 823 and for the construction of pT7ccII,
ucleotides 7576–8102 of human mitochondrial cyto-
hrome c oxidase II (GenBank Accession No.
C 001807) have been amplified with primers 788 and
89. Genomic DNA from human fibroblasts (generously
rovided by C. Krempe) served as template. The PCR
roducts were restricted with EcoRI and XhoI and ligated
nto the MCS of pSP73 (Promega).
Plasmids used for the in vitro degradation assay were
loned as follows: (i) pUH3 was modified by substitution
f its AatII/AflIII fragment with a linker consisting of
rimers 662 and 663, yielding pMCS, a cloning vector of
nly 1832 bp length; (ii) the nucleotides of its cloning site
etween EcoRV and BamHI were exchanged with a PCR
ragment of LTR1.4tatCAT using primers 683 and 684,
artially restricted with SmaI and BglII, resulting in pS/
CATpA. Due to an internal BglII site the isolated clone
id not contain the 59 end of the TAR region and the T7
romoter; (iii) pS/NCATpA was digested with SacI, the
nds were filled in with Klenow polymerase, and the
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287HIV-1 LEADER DEPENDENT GENE EXPRESSIONlinearized DNA was restricted with NcoI. The missing T7
TAR sequence of the PCR product was cloned into this
vector backbone after cutting with SmaI and NcoI, result-
ng in pT7TARS/NCATpA. To obtain the plasmids T71.4,
71.2.4, T71.3.4, and T71.2.3.4, the SacI/NcoI fragment of
T7TARS/NCATpA was exchanged with the correspond-
ng fragments of the LTR1.4tatCAT vector series.
All plasmid sequences whose construction involved
ynthetic oligonucleotides or PCR products were verified
y DNA sequencing.
NA isolation from nuclear and cytoplasmic cell
ractions
Cell fractionation was performed as described
Thomas et al., 1977). Briefly, 30 h after transfection,
eLa-T41 cells in 75-cm2 T-flasks were washed with
ice-cold phosphate-buffered saline (PBS) and hypotonic
washing buffer (1.5 mM KCl; 2.5 mM MgCl2; 5 mM Tris–
HCl, pH 7.4) and lysed for 10 min in 2 ml of ice-cold
hypotonic lysis buffer (1% Na-deoxycholate; 1% Triton
X-100; 1.5 mM KCl; 2.5 mM MgCl2; 5 mM Tris–HCl, pH
7.4). The cytoplasmic extract was removed and the flask
was washed with an additional 1 ml of lysis buffer.
Cellular debris and contaminating nuclei were removed
by centrifugation at 500 g, 0°C for 5 min. RNA was
extracted (Chomczynski and Sacchi, 1987) by adding 1
vol of preheated (80°C) 23 solution D (8 M guanidinium
isothiocyanate; 50 mM Na-acetate, pH 7.0; 1% N-lauroyl-
sarcosine; 0.2 M b-mercaptoethanol) to the supernatant.
he nuclei were scraped from the flask into 3 ml of
ypotonic washing buffer, sedimented by centrifugation
t 500 g, 0°C for 5 min, and dissolved in 600 ml of 13
olution D. After addition of 0.1 vol of 2 M Na-acetate, pH
.0, the RNA in the cytoplasmic and the nuclear fractions
as extracted with phenol/chloroform/isoamylalcohol,
recipitated with isopropanol, and resuspended in 50 ml
(cytoplasmic RNA) and 10 ml (nuclear RNA) water.
The cell fractionation protocol was monitored for con-
tamination of cytoplasmic and nuclear fractions by slot
blot hybridization using 2 mg of cytoplasmic or nuclear
RNA and antisense DIG-labeled cytochrome c oxidase II
RNA (pT7CCII) and b-actin intron RNA (pb-actin intron),
espectively.
NA stability measurements
Twenty-four hours after transfection of HeLa-T41 cells,
he medium was changed for DMEM supplemented with
CS (10%), amphotericin B (2.5 mg/ml), and actinomycin
(5 mg/ml). Total RNA was isolated at different time
oints from parallel cell cultures using RNA clean (5
l/107 cells, Hybaid-AGS). The RNA solution was vigor-
usly shaken with 0.1 vol of chloroform/isoamylalcohol
24:1, v:v) and centrifuged at 9200 g for 15 min. The RNAas precipitated with 1 vol isopropanol at 4°C o/n,
ashed with 70% EtOH, dried, and resuspended in
p
ndH2O. Poly(A)
1 RNA was separated with Dynabeads
oligo(dT)25 (Dynal) according to the manufacturer’s pro-
tocol and subjected to Northern blot analysis.
Western immunoblot analysis
Western blotting was performed as described (Schaal
et al., 1995), with additional normalization for transfection
efficiency and protein content. For normalization of trans-
fection efficiency, cells were cotransfected with plasmid
pGL3-control (Promega) and assayed for luciferase ac-
tivity (Lenz et al., 1997). After measurement of the protein
content, mock-transfected cell extract was added so that
the samples in one blot contained equal amounts of
protein and luciferase activity. The proteins were sepa-
rated on 0.1% SDS, 5–20% polyacrylamide gradient gels,
and electrotransferred to Immobilon-P membranes (Mil-
lipore). Blots were blocked overnight with PBS containing
10% bovine serum albumin (BSA) and 10% Tween 20. The
following steps were performed in PBS, 1% BSA, 1%
Tween 20. Blots were allowed to react with a monoclonal
antibody to gp120 (NEA-9305, DuPont, 1:500) for 1 h,
washed twice, incubated with sheep anti-mouse IgG
conjugated with horseradish peroxidase (HRP, 1:1000,
Amersham) for 1 h, washed four times, and rinsed with
water. For detection of luciferase, blots were subse-
quently reacted with a polyclonal rabbit anti-luciferase
antibody (1:2500, Promega) and a donkey anti-rabbit IgG
conjugated with HRP (1:500, Amersham). The bands
were visualized with the Western blot ECL system on
ECL hyperfilm (Amersham).
Nuclear degradation assay
The T7 constructs were linearized with SalI, phenol/
chloroform extracted, precipitated with 2.5 vol EtOH,
washed with 70% EtOH, and resuspended in 10 ml TE.
inearized DNA (1 mg) was subjected to an in vitro
transcription reaction using 10 U T7 RNA polymerase
(Roche Molecular Biochemicals), 400 mM ATP, CTP, GTP
each), 40 mM UTP, and 20 mCi [a-32P]UTP (800 Ci/mmol,
Amersham) for 60–120 min. For capping of the transcripts
100 mM GTP and 1 mM GpppG cap-analog (Amersham)
ere used. The transcripts were separated in a 7 M urea
% denaturing polyacrylamide gel (National Diagnos-
ics), excised, and eluted overnight in 0.3 M Na-acetate,
mM EDTA at 4°C. Transcripts were extracted with
henol/chloroform, precipitated, and resuspended in 20
ml renaturation buffer (140 mM KCl, 20 mM Tris–Cl pH
7.8). Transcripts were incubated for 1 min at 90°C, 15 min
at 60°C, and cooled to 30°C within 15 min. MgCl2 was
dded to a final concentration of 2.5 mM and the tran-
cripts were incubated an additional 15 min at 30°C. The
enatured transcripts were kept on ice (Kjems et al.,
998). Equal Cerenkov counts of each transcript were
ooled and subjected to degradation in a HeLa cell
uclear extract (Computer Cell Culture, Belgium) that
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288 KRUMMHEUER ET AL.was prepared according to Dignam et al. (1983). Degra-
dation was carried out at 30°C in the presence of 0.4 mM
NTPs, 75 mM creatine phosphate, 1.5 mM DTT, 5 mM
MgCl2, and 44% (v/v) nuclear extract. Aliquots taken dur-
ng degradation were mixed with 8 vol of stopping solu-
ion (0.3 M Tris–HCl, pH 7.4, 0.3 M Na-acetate, 0.5% SDS,
mM EDTA, 3 mg/ml tRNA) extracted with phenol/chlo-
oform, precipitated, and resuspended in 20 ml TE. Equal
Cerenkov counts of different times were subjected to
denaturing polyacrylamide electrophoresis. Quantifica-
tion of the degradation products was achieved by using
the PhosphorImaging Plate Scanner (Fujifilm BAS-1500)
and Raytest software TINA 2.09.
PCR, transfection, CAT ELISA, Northern blot analysis,
and nuclear run-on transcription assay
These techniques were performed as described pre-
viously (Lenz et al., 1997), or as indicated in the figure
legends.
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